Erik H Serne
Overview
Explore the profile of Erik H Serne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
1912
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zelis M, Simonis A, van Dam R, Boomsma D, van Lee L, Kramer M, et al.
Nutrients
. 2024 Oct;
16(20).
PMID: 39458507
Aims: Various dietary risk factors for type 2 diabetes have been identified. A short assessment of dietary patterns related to the risk for type 2 diabetes mellitus may be relevant...
2.
Woudstra J, Mourmans S, Vink C, Marques K, de Jong E, Haddad R, et al.
Am J Physiol Heart Circ Physiol
. 2024 Aug;
327(4):H1086-H1097.
PMID: 39212772
Coronary vasomotor dysfunction, an important underlying cause of angina and nonobstructive coronary arteries (ANOCA), encompassing coronary vasospasm, coronary endothelial dysfunction, and/or coronary microvascular dysfunction, is clinically assessed by invasive coronary...
3.
Doornweerd S, van den Born B, Collard D, Serne E, Smulders Y
Ned Tijdschr Geneeskd
. 2024 Aug;
168.
PMID: 39132901
Isolated systolic hypertension is typical for the elderly, but also occurs in younger adults. Increased pulse wave amplification between the elastic aorta and arteries to the arm can result in...
4.
Bak J, de Vries S, Serne E, Groenwold R, de Valk H, Mul D, et al.
Diabetes Obes Metab
. 2024 Jul;
26(10):4213-4224.
PMID: 39072872
Aim: Diabetes mellitus is a major cause of death. Outpatients with diabetes have more complications than patients in general practice; mortality patterns have only been studied in the total diabetes...
5.
Helmink M, Hageman S, Eliasson B, Sattar N, Visseren F, Dorresteijn J, et al.
Diabetes Obes Metab
. 2024 Mar;
26(6):2229-2238.
PMID: 38456579
Aims: To develop and externally validate the LIFE-T1D model for the estimation of lifetime and 10-year risk of cardiovascular disease (CVD) in individuals with type 1 diabetes. Materials And Methods:...
6.
Jancev M, Vissers T, Visseren F, van Bon A, Serne E, DeVries J, et al.
Diabetologia
. 2024 Feb;
67(5):798-810.
PMID: 38363342
Aims/hypothesis: Continuous glucose monitoring (CGM) is increasingly used in the treatment of type 2 diabetes, but the effects on glycaemic control are unclear. The aim of this systematic review and...
7.
Bak J, Serne E, Wouters M, de Valk H, Mul D, Sas T, et al.
Diabetes Metab Syndr
. 2023 Dec;
18(1):102920.
PMID: 38113808
Background: Diabetes mellitus forms a slow pandemic. Cardiovascular risk and quality of diabetes care are strongly associated. Quality indicators improve diabetes management and reduce mortality and costs. Various national diabetes...
8.
Serne E, Sikkens J, IJzerman R
Ned Tijdschr Geneeskd
. 2023 Nov;
167.
PMID: 37930171
In persons with type 2 diabetes without established cardiovascular complications data are lacking on the comparative effectiveness of commonly used glucose-lowering medications, when added to metformin, with respect to glycemic...
9.
Bak J, Serne E, Groenwold R, de Valk H, Kramer M, Nieuwdorp M, et al.
Diabetol Metab Syndr
. 2023 Oct;
15(1):193.
PMID: 37817214
Aims: The COVID-19 pandemic impacted diabetes care by reducing diabetes outpatient visits and diabetes-related screening due to allocation of healthcare resources. Yet the impact of COVID-19 on diabetes outpatients has...
10.
Serne E, Overbeek J, Palmen J, de Jong H, Stehouwer C
Ned Tijdschr Geneeskd
. 2023 Sep;
167.
PMID: 37742128
Objective: Dutch diabetes guidelines have been updated to incorporate specific therapies with cardiovascular and kidney outcomes benefit in type 2 diabetes patients (T2D) at very high risk for cardiorenal complications....